- Home
- OPP vs GLSI Comparison
OPP vs GLSI Comparison
Compare OPP & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPP | GLSI |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.4M | 187.9M |
| IPO Year | 2016 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OPP | GLSI |
|---|---|---|
| Price | $7.67 | $16.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $50.00 |
| AVG Volume (30 Days) | 79.8K | ★ 162.6K |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | ★ 14.41% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.47 | $7.78 |
| 52 Week High | $8.77 | $34.10 |
Technical Indicators
Market Signals| Indicator | OPP | GLSI |
|---|---|---|
| Relative Strength Index (RSI) | 54.63 | 51.18 |
| Support Level | $7.50 | $12.51 |
| Resistance Level | $7.74 | $29.89 |
| Average True Range (ATR) | 0.08 | 1.12 |
| MACD | 0.01 | 0.64 |
| Stochastic Oscillator | 79.93 | 73.40 |
Price Performance
Historical ComparisonAbout OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.